These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34350690)
1. Organic Sonosensitizers for Sonodynamic Therapy: From Small Molecules and Nanoparticles toward Clinical Development. Li D; Yang Y; Li D; Pan J; Chu C; Liu G Small; 2021 Oct; 17(42):e2101976. PubMed ID: 34350690 [TBL] [Abstract][Full Text] [Related]
2. Design and application of inorganic nanoparticles for sonodynamic cancer therapy. Sun L; Wang P; Zhang J; Sun Y; Sun S; Xu M; Zhang L; Wang S; Liang X; Cui L Biomater Sci; 2021 Mar; 9(6):1945-1960. PubMed ID: 33522523 [TBL] [Abstract][Full Text] [Related]
3. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Pan X; Wang H; Wang S; Sun X; Wang L; Wang W; Shen H; Liu H Sci China Life Sci; 2018 Apr; 61(4):415-426. PubMed ID: 29666990 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Assisted Sonosensitizers and Their Biomedical Applications. Zhao P; Deng Y; Xiang G; Liu Y Int J Nanomedicine; 2021; 16():4615-4630. PubMed ID: 34262272 [TBL] [Abstract][Full Text] [Related]
5. Inorganic Sonosensitizers for Sonodynamic Therapy in Cancer Treatment. Cao X; Li M; Liu Q; Zhao J; Lu X; Wang J Small; 2023 Oct; 19(42):e2303195. PubMed ID: 37323087 [TBL] [Abstract][Full Text] [Related]
6. Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers. Gong Z; Dai Z Adv Sci (Weinh); 2021 May; 8(10):2002178. PubMed ID: 34026428 [TBL] [Abstract][Full Text] [Related]
7. Stimuli responsive nanosonosensitizers for sonodynamic therapy. Jiang Z; Xiao W; Fu Q J Control Release; 2023 Sep; 361():547-567. PubMed ID: 37567504 [TBL] [Abstract][Full Text] [Related]
8. Recent Developments of Inorganic Nanosensitizers for Sonodynamic Therapy. He Z; Du J; Miao Y; Li Y Adv Healthc Mater; 2023 Sep; 12(22):e2300234. PubMed ID: 37070721 [TBL] [Abstract][Full Text] [Related]
9. Natural products in the discovery of novel sonosensitizers. Pang X; Xu C; Jiang Y; Xiao Q; Leung AW Pharmacol Ther; 2016 Jun; 162():144-51. PubMed ID: 26706240 [TBL] [Abstract][Full Text] [Related]
10. Patient-derived microvesicles/AIE luminogen hybrid system for personalized sonodynamic cancer therapy in patient-derived xenograft models. Duo Y; Zhu D; Sun X; Suo M; Zheng Z; Jiang W; Tang BZ Biomaterials; 2021 May; 272():120755. PubMed ID: 33819814 [TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy. Chen P; Zhang P; Shah NH; Cui Y; Wang Y Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569377 [TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy. Liang S; Deng X; Ma P; Cheng Z; Lin J Adv Mater; 2020 Nov; 32(47):e2003214. PubMed ID: 33064322 [TBL] [Abstract][Full Text] [Related]
13. Metal-Organic Frameworks (MOF)-Assisted Sonodynamic Therapy in Anticancer Applications. Yang F; Dong J; Li Z; Wang Z ACS Nano; 2023 Mar; 17(5):4102-4133. PubMed ID: 36802411 [TBL] [Abstract][Full Text] [Related]
14. Recent Progress Toward Imaging Application of Multifunction Sonosensitizers in Sonodynamic Therapy. Wang C; Tian Y; Wu B; Cheng W Int J Nanomedicine; 2022; 17():3511-3529. PubMed ID: 35966148 [TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging-Guided Sonodynamic Therapy. Guo J; Pan X; Wang C; Liu H Bioconjug Chem; 2022 Jun; 33(6):993-1010. PubMed ID: 34595922 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Activated Sensitizers and Applications. Lin X; Song J; Chen X; Yang H Angew Chem Int Ed Engl; 2020 Aug; 59(34):14212-14233. PubMed ID: 31267634 [TBL] [Abstract][Full Text] [Related]
17. Metal-organic frameworks as candidates for tumor sonodynamic therapy: Designable structures for targeted multifunctional transformation. Yang Y; Wang N; Yan F; Shi Z; Feng S Acta Biomater; 2024 Jun; 181():67-97. PubMed ID: 38697383 [TBL] [Abstract][Full Text] [Related]
18. Organic Sonodynamic Materials for Combination Cancer Immunotherapy. Zhang C; Pu K Adv Mater; 2023 Dec; 35(51):e2303059. PubMed ID: 37263297 [TBL] [Abstract][Full Text] [Related]